Familial Nasopharyngeal Carcinoma 6

192 A. W. M. LeeLee AW, Lau WH, Tung SY, et al (2005a) Preliminary results of arandomized study on therapeutic gain by concurrent chemotherapyfor regionally-advanced nasopharyngeal carcinoma:NPC-9901 Trial by the Hong Kong NasopharyngealCancer Study Group. J Clin Oncol 23: 6966–6975Lee AW, Sze WM, Au SK, et al (2005b) Treatment results fornasopharyngeal carcinoma in the modern era: the HongKong experience. Int J Radiat Oncol Biol Phys 61:1107–1116Lee AW, Tung SY, Chan AT, et al (2006) Preliminary results of arandomized study (NPC-9902 Trial) on therapeutic gain byconcurrent chemotherapy and/or accelerated fractionationfor locally-advanced nasopharyngeal carcinoma. Int J RadiatOncol Biol Phys 66:142–151Lee AW, Yau TK, Wong HM, et al (2005c) Treatment of stageIV(A–B) nasopharyngeal carcinoma by inductionconcurrentchemoradiotherapy and accelerated fractionation.Int J Radiat Oncol Biol Phys 63:1331–1338Lee N, Xia P, Quivey JM, et al (2002) Intensity-modulatedradiotherapy in the treatment of nasopharyngeal carcinoma:an update of the UCSF experience. Int J Radiat OncolBiol Phys 53(1):12–22Lin JC, Chen KY, Jan JS, et al (1996) Partially hyperfractionatedaccelerated radiotherapy and concurrent chemotherapy foradvanced nasopharyngeal carcinoma. Int J Radiat OncolBiol Phys 36:1127–1136Ma BB, Tannock IF, Pond GR, et al (2002) Chemotherapy withgemcitabine-containing regimens for locally recurrent ormetastatic nasopharyngeal carcinoma. Cancer 95: 2516–2523Ma J, Mai HG, Hong MH, et al (2001) Results of a prospectiverandomized trial comparing neoadjuvant chemotherapyplus radiotherapy versus radiotherapy alone in patientswith locoregionally advanced nasopharyngeal carcinoma.J Clin Oncol 19:1350–1357Ngan RK, Yiu HH, Lau WH, et al (2002) Combination gemcitabineand cisplatin chemotherapy for metastatic or recurrentnasopharyngeal carcinoma: report of a phase II study.Ann Oncol 13:1252–1258Oh JL, Vokes EE, Kies MS, et al (2003) Induction chemotherapyfollowed by concomitant chemoradiotherapy in the treatmentof locoregionally advanced nasopharyngeal cancer. AnnOncol 14:564–569Richman SP, Livingston RB, Gutterman JU, et al (1976)Chemotherapy versus chemoimmunotherapy of head andneck cancer: report of a randomized study. Cancer TreatRep 60:535–539Rischin D, Corry J, Smith J, et al (2002) Excellent disease controland survival in patients with advanced nasopharyngeal cancertreated with chemoradiation. J Clin Oncol 20: 1845–1852Sobin L (2002) International Union Against Cancer (UICC):TNM classification of malignant tumors, 6th edn. Wiley,New YorkTannock I, Payne D, Cummings B, et al (1987) Sequential chemotherapyand radiation for nasopharyngeal cancer:absence of long-term benefit despite a high rate of tumorresponse to chemotherapy. J Clin Oncol 5(4):629–634Webster K, Cella D, Yost K (2003) The Functional Assessmentof Chronic Illness Therapy (FACIT) Measurement System:properties, applications, and interpretation. Health QualLife Outcomes 1:79–85Wee J, Tan EH, Tai BC, et al (2005) Randomized trial of radiotherapyversus concurrent chemoradiotherapy followed byadjuvant chemotherapy in patients with American JointCommittee on Cancer/International Union Against CancerStage III and IV nasopharyngeal cancer of the endemicvariety. J Clin Oncol 23:6730–6738Wolden SL, Zelefsky MJ, Kraus DH, et al (2001) Accelerated concomitantboost radiotherapy and chemotherapy for advancednasopharyngeal carcinoma. J Clin Oncol 19: 1105–1110Yau TK, Lee AW, Wong DH, et al (2006b) Treatment of stageIV(A–B) nasopharyngeal carcinoma by induction-concurrentchemoradiotherapy and accelerated fractionation:impact of chemotherapy schemes. Int J Radiat Oncol BiolPhys 66:1004–1010Yau TK, Lee AW, Wong HM, et al (2006a) Induction chemotherapywith cisplatin and gemcitabine followed by acceleratedradiotherapy and concurrent cisplatin in patientswith stage IV(A–B) nasopharyngeal carcinoma. Head Neck28:880–887